{'Year': '2018', 'Month': 'Dec'}
Analysis of outpatient HER2 testing in New York state using the statewide planning and research cooperative system.
HER2 testing is necessary in the context of therapy with trastuzumab, pertuzumab, lapatinib and neratinib. There is a paucity of reports describing the utilization rates of HER2 testing in large outpatient populations.